MedPage Today1d
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Managed Healthcare Executive3d
The Power of PBMs and Biosimilars, 2025 Launches of the Stelara Biosimilars, the IRA and Interchangeability | Q&A with Craig Burton, MBA
The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...
pharmaphorum7d
Questions about Humira biosimilars?
in 2010 provided an abbreviated approval pathway for biosimilars. Other types of biosimilars, such as oncology drugs, have since gained widespread usage. Humira biosimilars have had FDA approval ...
pharmaphorum3d
Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy
South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab ... the backbone of treatment across multiple tumour types, and earned $3.8 billion for Merck in 2017.
centerforbiosimilars3d
Psoriasis Biosimilars Saved VA $67 Million in 2023
The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...
Managed Healthcare Executive4d
Health of the Biosimilars Industry, Getting Rid of Clinical Trials, PBMs As Obstacles and Other Biosimilar Topics | Q&A With Craig Burton, MBA
We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Business Wire3h
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe ...